Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Data (including data from studies using knockout mice) suggest that S100A1 (show S100A1 Antibodies) (S-100 calcium-binding protein (show GUCA1B Antibodies) A1 (show BCL2A1 Antibodies), alpha chain (show FCGRT Antibodies)) is involved in protein kinase A- (RIIalpha and RIIbeta)-dependent signaling resulting in nuclear redistribution/influx of HDAC4 (histone deacetylase 4 (show HDAC5 Antibodies)) in skeletal muscle fibers.
RIIbeta-PKA modulates the duration of leptin receptor (show LEPR Antibodies) signalling and therefore the magnitude of the catabolic response to leptin (show LEP Antibodies).
RIIBeta protein kinase A knockout was protective against induced seizure susceptibility.
Deficiency of the RIIbeta subunit of PKA affects locomotor activity and energy homeostasis in distinct neuronal populations.
study describes the 2.3 angstrom structure of full-length tetrameric RIIbeta(2):C(2) holoenzyme
Conditioned taste aversion (CTA (show PCYT1A Antibodies)) learning was examined in mice with a targeted disruption of a gene for a specific regulatory subunit of PKA (RIIbeta), which is selectively expressed in amygdala. Disruption of PKA signaling interferes with CTA (show PCYT1A Antibodies).
RII-PKAII complements TSHR (show TSHR Antibodies) action by stably propagating robust cAMP signals in cell compartments
Here we show that visual cortical plasticity remains intact in AC1 (show HRASLS Antibodies)/AC8 (show ADCY8 Antibodies)-/- mice, whereas Ocular dominance plasticity and LTD, but not LTP (show SCP2 Antibodies), are absent in RIIbeta-/- mice
Disruption of the RIIbeta regulatory subunit of protein kinase A (PKA) results in mice with a lean phenotype, nocturnal hyperactivity, and increased resting metabolic rate.
increased ingestion of ethanol by protein kinase A(PKA) subunit RIIbeta(-/-) mice is likely the result of altered PKA activity within neuronal pathways that control ethanol-consummatory behaviors
Leu206Arg and Leu199_Cys200insTrp mutations in PRKACA (show PRKACA Antibodies) impair its association with PRKAR2B and PRKAR1A (show PRKAR1A Antibodies).
Although the depletion of PRKAR1A (show PRKAR1A Antibodies) and PRKAR2B in adrenocortical cells has similar effects on cell proliferation and apoptosis; loss of these PKA subunits differentially affects cyclin (show PCNA Antibodies) expression.
Because of limited power, PRKAR2B's role in antipsychotic-induced weight gain is unclear, but biological evidence suggests that PRKAR2B may be involved
lipolytic catecholamine resistance of sc adipocytes in polycystic ovary syndrome is probably due to a combination of decreased amounts of beta(2)-adrenergic receptors, the regulatory II beta-component of protein kinase A, and hormone-sensitive lipase (show LIPE Antibodies)
Nuclear RII beta can act as a repressor of CREB (show CREB1 Antibodies) transcriptional activity in T cells, providing a potential functional significance for aberrant levels of nuclear RII beta in systemic lupus erythematosus T cells.
there are abnormalities in [3H]cAMP binding and catalytic activity kinase A in brain of depressed suicide victims, which could be due to reduced expression of RIIbeta and Cbeta
serine 114 phosphorylation and nuclear localization of RIIbeta controls the regulation of IL-2 (show IL2 Antibodies) gene expression in T cells.
Loss of PRKAR2B protein due to a post-transcriptional mechanism in ACA-S is a new mechanism of cAMP pathway dysregulation in adrenocortical tumorigenesis.
PKA RII(beta) is responsible for increased glucocorticoid sensitivity, critical for cAMP-mediated synergistic cell killing in CEM cells
both the constitutive and cAMP-induced release of TNFR1 (show TNFRSF1A Antibodies) exosome-like vesicles occur via PKA-dependent pathways that are regulated by the anchoring of RIIbeta to BIG2 (show ARFGEF2 Antibodies) via AKAP (show AKAP1 Antibodies) domains B and C
angle X-ray scattering studies indicate that the RIalpha (show PRKAR1A Antibodies), RIIalpha, and RIIbeta homodimers differ markedly in overall shape, despite extensive sequence homology and similar molecular masses
cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. The protein encoded by this gene is one of the regulatory subunits. This subunit can be phosphorylated by the activated catalytic subunit. This subunit has been shown to interact with and suppress the transcriptional activity of the cAMP responsive element binding protein 1 (CREB1) in activated T cells. Knockout studies in mice suggest that this subunit may play an important role in regulating energy balance and adiposity. The studies also suggest that this subunit may mediate the gene induction and cataleptic behavior induced by haloperidol.
protein kinase, cAMP-dependent, regulatory, type II, beta
, cAMP-dependent protein kinase, regulatory subunit beta 2
, cAMP-dependent protein kinase type II-beta regulatory subunit-like
, protein kinase, cAMP dependent regulatory, type II beta
, cAMP-dependent protein kinase type II-beta regulatory subunit
, Type II beta regulatory subunit of cAMP-dependent protein kinase
, cAMP-dependent protein kinase type II-beta regulatory chain